ClinicalTrials.Veeva

Menu

'Dialogue and Guidance' - a Policy Intervention for Improved OHS Among Workplaces With WEA Violations

D

Danish Labor Inspectorate

Status

Unknown

Conditions

Safety Issues
Occupational Diseases
Occupational Injuries

Treatments

Behavioral: Dialogue and guidance over telephone
Behavioral: Treatment as usual
Behavioral: Dialogue and guidance at physical meeting

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

With the aim to inspire and motivate workplaces in their work to prevent and reduce occupational health and safety hazards, the Danish Working Environment Authority (WEA) developed the intervention 'Dialogue and Guidance' aimed at workplaces receiving notices (prohibition notice, immediate improvement notice and notice with time limit) from WEA during inspections. At present, WEA gives dialogue and guidance as standard practice during WEA inspections to all workplaces receiving a notice with the purpose to help workplaces resolve the occupational health and safety problem that led to the notice. In the intervention 'Dialogue and Guidance' the experimental groups are receiving additional dialogue and guidance at a subsequent meeting (over the telephone or physical presence) that takes place after the inspection and after the deadline for appealing the notice has expired. The control group is receiving dialogue and guidance during inspection as usual.

The aim of this RCT study is to evaluate the policy-developed intervention with additional 'Dialogue and Guidance' in regards to the effect on motivation and priority of occupational health and safety work at the workplace after 6 months follow-up and for WEA notices by next WEA inspection (approx. follow-up by 12-18 months).

Study is risk assessed and approved under Danish Data Protection Agency via the National Research Centre for the Working Environment's umbrella approval.

Enrollment

4,500 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Subjects under inspection are workplaces, and respondents of the questionnaires are the workplace manager and a work environment representative or shop steward.

Inclusion Criteria:

• Workplaces (production units) who receives a WEA notice during WEA inspection through the period of intervention. The following WEA notices are included:

  • Immediate improvement notice
  • Notice with time limit (material)

Exclusion Criteria:

  • Companies with 0-1 employees.
  • Production units from the construction industry met on temporary worksites (such as construction sites) that have more than one employee and does not have a certified occupational health and safety management system.
  • Companies receiving notices only about issues in the formal/procedural aspects of the work environment (such as flaws in the workplace risk assessment) and no other notices.
  • Companies receiving more than four reactions from WEA at the inspection (as these receive a competency notice and are not included in the study).
  • Companies that receive a prohibition notice by the WEA inspector due to severity of work environment violations.
  • A WEA improvement notice is not eligible for inclusion in the study if the workplace has entered into a collaborative agreement with WEA on improvement of the issue, or if they have received a competency notice on the WEA issue.
  • Companies receiving WEA inspections in relation to initiatives targeting social dumping

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

4,500 participants in 3 patient groups

Comparison group
Active Comparator group
Treatment:
Behavioral: Treatment as usual
Telephone D&G
Experimental group
Treatment:
Behavioral: Dialogue and guidance over telephone
Physical meeting D&G
Experimental group
Treatment:
Behavioral: Dialogue and guidance at physical meeting

Trial contacts and locations

1

Loading...

Central trial contact

Jesper Sørensen, Msc; Thomas S. Rexen, Msc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems